Parabon NanoLabs, Inc. is a vertically integrated DNA technology company that develops next-generation therapeutic and forensic products, which leverage the enormous power of DNA. Staffed by a uniquely qualified team of scientists and technologists, with expertise ranging from bioinformatics and oncology to chemistry and computer science, the Company is bringing to market revolutionary new products and services made possible by recent advances in DNA sequencing, processing and manufacturing technologies.
Organized in the State of Delaware, Parabon NanoLabs is a for-profit, C-Corporation with headquarters in Reston, Virginia.
The Company is a small business as defined by the US Government’s Small Business Administration and is the recipient of numerous Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants and contracts.
Established in 2008, as an on-going collaboration between Dr. Michael Norton, a pioneer in the field of DNA-based nanotechnology, and Dr. Steven Armentrout, serving as CEO of Parabon Computation (PCI). Parabon NanoLabs recently moved into the field of forensic investigation, through the developing trait prediction capabilities for forensics applications.